BTG3 and systemic lupus erythematosus: Our findings revealed that 30 % of the SLE patients were negative for ANA, which was in agreement with the findings of studies from Iran [24], while the percentage of patients who were positive for ANA in other regions of Iran was 70–98 % [29,30].